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Abstract: One integral step in the transition from a nucleic acid encoded-genome to functional proteins
is the aminoacylation of tRNA molecules. To perform this activity, aminoacyl-tRNA synthetases
(aaRSs) activate free amino acids in the cell forming an aminoacyl-adenylate before transferring the
amino acid on to its cognate tRNA. These newly formed aminoacyl-tRNA (aa-tRNA) can then be used
by the ribosome during mRNA decoding. In Escherichia coli, there are twenty aaRSs encoded in the
genome, each of which corresponds to one of the twenty proteinogenic amino acids used in translation.
Given the shared chemicophysical properties of many amino acids, aaRSs have evolved mechanisms
to prevent erroneous aa-tRNA formation with non-cognate amino acid substrates. Of particular
interest is the post-transfer proofreading activity of alanyl-tRNA synthetase (AlaRS) which prevents
the accumulation of Ser-tRNAAla and Gly-tRNAAla in the cell. We have previously shown that
defects in AlaRS proofreading of Ser-tRNAAla lead to global dysregulation of the E. coli proteome,
subsequently causing defects in growth, motility, and antibiotic sensitivity. Here we report second-site
AlaRS suppressor mutations that alleviate the aforementioned phenotypes, revealing previously
uncharacterized residues within the AlaRS proofreading domain that function in quality control.
Keywords: aminoacyl-tRNA synthetases; tRNA; translational fidelity
1. Introduction
Across all domains of life, protein-coding sequences have evolved to maintain activity of essential
biological processes. Specific residues or modular domains with high evolutionary conservation
within a polypeptide sequence can provide insight into regions of functional essentiality of a given
protein [1,2]. Because of this, mechanisms have also evolved to minimize errors in protein synthesis [3].
Translational fidelity is maintained at several distinct stages of protein synthesis, with one of
the key steps being the accuracy of aminoacyl-tRNA synthesis by aaRSs. AaRSs are responsible
for pairing free amino acids in the cell to their cognate tRNAs, with the product then released for
participation in ternary complex formation with elongation factor and GTP [4]. This complex is
then recruited to the A-site of the ribosome to facilitate peptide bond formation. Most organisms
encode at least one distinct aaRS gene for each of the twenty proteinogenic amino acids in the
cell. In complex with ATP, aaRSs bind to free cognate amino acids leading to the synthesis of an
aminoacyl-adenylate. This activated amino acid will then be transferred to the 3′ end of the tRNA to
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be released in the cell for translation. AaRSs have evolved mechanisms to prevent the accumulation of
mis-aminoacylated tRNAs. Half of the aaRSs in Escherichia coli are able to occlude non-cognate amino
acid activation in the primary active site; however, the other ten aaRS will mis-activate non-cognate
substrates [5]. To prevent non-cognate aa-tRNAs from being released into the cell, many aaRSs have
evolved secondary mechanisms to hydrolyze non-cognate products. Several synthetases, including
isoleucyl-tRNA synthetase have evolved hydrolytic activity against non-cognate amino acids at the
amino acid activation site. Upon non-cognate adenylate recognition, the amino acid and AMP will be
hydrolyzed and released back into the cell [6]. In contrast, several aaRS including, phenylalanyl-tRNA
synthetase (PheRS) [7], threonyl-tRNA synthetase (ThrRS) [8], and alanyl-tRNA synthetase (AlaRS) [9]
encode a distinct secondary active site which contains proofreading activity against non-cognate amino
acid-containing substrates after the amino acid is transferred to the 3′ end of the tRNA.
While considerable work has been devoted to characterizing the enzymatic activity of aaRSs,
the exploration of the role of these enzymes in vivo has only been recently investigated [10–13]. It was
previously observed that an alanine substitution of an essential cysteine in the AlaRS proofreading
domain leads to mis-aminoacylation of serine on tRNAAla in vitro [9]. E. coli with the same substitution
(AlaRS C666A) show defects in maintaining proteome homeostasis in E. coli [13]. To expand on
these efforts, we sought to identify suppressors of the AlaRS C666A phenotype in hopes of further
characterizing the mechanisms by which AlaRS fidelity promotes cellular homeostasis. In this work,
we identify and characterize two additional residues in E. coli AlaRS that play roles in enzymatic
activity. All of the novel suppressors appear to modulate AlaRS fidelity through unique and distinct
mechanisms. Furthermore, the observations presented herein suggest that a slight increase in AlaRS
proofreading activity may be sufficient to alleviate the AlaRS C666A-associated physiological defects.
More broadly, this work demonstrates the utility of applying genetic approaches to further elucidate
novel mechanistic features of aaRSs.
2. Materials and Methods
2.1. General Methods
Lysogeny broth (LB) was used for all growth experiments in rich media. M9 media was prepared
for the minimal media experiment supplemented with exogenous serine [13]. SOB and SOC media were
used for CRISPR/Cas9-mediated strain engineering. When applicable, antibiotics were supplemented
at the following concentrations: kanamycin, 25 µg/mL; ampicillin, 100 µg/mL for selection and
20 µg/mL for mistranslation reporter; chloramphenicol 30 µg/mL; spectinomycin 50 µg/mL. All DNA
oligonucleotides were synthesized by Sigma Aldrich (St. Louis, MO, USA).
2.2. Suppressor Mutant Characterization
Suppressor mutant colonies were isolated and genomic DNA was collected using the Wizard
Genomic DNA Purification Kit (Promega, Madison, WI, USA) following manufacturer recommendations.
For whole-genome sequencing analysis, 50 ng of genomic DNA was sheared using a Covaris E220
ultrasonicator (Woburn, MA, USA), and sequencing libraries were subsequently prepared using the KAPA
Hyper Prep Kit (KAPA Biosystems, Basel, Switzerland). Sequencing was performed on an Illumina
HiSeq4000 sequencer (Illumina Inc., San Diego, CA, USA) following the PE150 protocol. Sequencing
data were uploaded to the public server at usegalaxy.org and sequencing fragments ranging between
35–151 bp were analyzed using the Galaxy web platform [14]. AlaRS C666A suppressor mutations were
also identified using Sanger sequencing of PCR-amplified fragments of the AlaRS editing domain.
AlaRS protein sequences were aligned using the EMBL-EBI Clustal Omega multiple sequence
alignment tool [15] and visualized using Jalview [16]. Positions of the suppressor-substituted amino
acids were modeled using Phyre2 [17] and visualized using PyMOL software.
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2.3. Strain Construction
The AlaRS C666A suppressor in alaS at nucleotide position G1651T (encoding AlaRS D551Y)
was made in an isogenic MG1655 strain using the “gene gorging” method as has previously been
described [13]. Suppressor mutations encoding substitutions at R561 were also generated in isogenic
MG1655 derivative strains. These four strains (single R561C and R561S variants and double R561C/S
C666A variants) were constructed using CRISPR/Cas9 genome engineering [18,19]. Following the
cloning strategies described by Reisch and colleagues, the suppressor strains were constructed and
validated by Sanger sequencing of the AlaRS proofreading domain amplicon.
2.4. Growth Analysis
For all growth experiments, saturated overnight cultures were normalized and back-diluted to an
OD600 of 0.05 in the respective experimental media. Cultures were then incubated at either 37 ◦C or
42 ◦C and OD600 values were monitored using a CO8000 cell density meter (WPA) at 30′ time intervals.
The data plotted are the averages of three biological replicates with error bars indicating the standard
deviation of the replicates.
2.5. Motility Assays
To monitor changes in E. coli motility, swimming plates were prepared using LB media
supplemented with 0.2% agar. Saturated overnight cultures were normalized to an OD600 of 0.5 and
0.5 µL of cells were spotted on the agar plates. The swimming plates were incubated at 37 ◦C for 8 h
prior to imaging. E. coli motility was quantified by measuring the swimming diameter using ImageJ.
2.6. Antibiotic Sensitivity
Sensitivity to antibiotic exposure was monitored by streaking bacterial lawn cultures on LB agar
plates and co-incubation with Oxoid antibiotic disks (Thermo Fisher, Waltham, MA, USA). Plates were
incubated overnight at 37 ◦C and the sensitivities to ertapenem and polymixin B were quantified by
measuring the diameter of antibiotic clearing using ImageJ.
2.7. In vivo Mistranslation Reporter
The construction and utility of the pLK-Amp S68A mistranslation reporter have been previously
described [13]. In brief, β-lactamase, a gene product used for conferring ampicillin resistance, contains
an essential serine residue at position S68. By mutating the gene to encode for an alanine residue
at the 68 position, active β-lactamase translation is dependent upon mistranslation of the alanine to
serine at that position. The aforementioned mistranslation event can be monitored by the ability of
microbial growth in the presence of ampicillin. Reporter plasmids containing either wild-type or
mutant β-lactamase genes were transformed into all of the MG1655 AlaRS C666A suppressor strains.
The resulting strains were struck onto LB agar plates containing ampicillin and growth was monitored
after 48 h of growth at 37 ◦C.
2.8. Preparation of Recombinant Protein and In Vitro Transcribed tRNAAla
Genes encoding wild-type AlaRS or the AlaRS C666A variant were cloned into pET21b at NdeI
and XhoI restriction sites. The aforementioned cloning strategy generated an in-frame C-terminal
His-tag for metal affinity purification as previously described [13]. To characterize the biochemical
activity of the suppressor mutations, site-directed mutagenesis was used to create single and double
mutant AlaRS expression constructs. Active enzyme concentrations were determined by active site
titration [13,20].
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In vitro transcribed E. coli tRNAAla was prepared by slow cooling partially overlapping synthetic
DNA oligonucleotides which encode for a T7 promoter and the most abundant tRNAAla isoacceptor in
E. coli (genes: alaT, alaU, and alaV). The annealed fragments were then ligated and cloned into EcoRI
and XbaI restriction sites in pUC18. Plasmid containing the E. coli tRNAAla gene was used as a template
for PCR amplification of the T7 promoter and tRNA. The PCR-amplified product was subsequently
used for T7 runoff transcription. In vitro transcription was performed as previously described [21] and
the tRNA was purified using anion exchange chromatography.
2.9. Proofreading Activity
To determine if the AlaRS suppressor variants led to changes in mis-aminoacylation in vitro,
all single and double mutant AlaRS variants were used for in vitro mis-serylation experiments.
To monitor mis-aminoacylation, 5 µM AlaRS was incubated with 5 µM tRNAAla, 750 µM [3H]-Ser,
aminoacylation buffer (100 µM HEPES pH 7.2, 30 mM KCl, and 10 mM MgCl2), and initiated with
8 mM ATP. Mis-serylation reactions were carried out for at 37 ◦C 15 min and radiolabeled signal was
determined by TCA precipitation and subsequent quantification by scintillation counting.
Beyond mis-aminoacylation, trans proofreading activity was monitored to determine if the
suppressor mutants altered aminoacyl-tRNA re-binding and subsequent proofreading. To generate
pre-formed aa-tRNAAla, recombinant EF-Tu was first activated (EF-Tu expression construct was
generously provided by Dr. Kurt Fredrick, Ohio State University). EF-Tu activation was performed by
incubating 50 µM EF-Tu with 50 mM Tris pH 7.8, 100 µM DTT, 68 mM KCl, 6.7 mM MgCl2, 2.5 mM
phosphoenol pyruvate, 30 µg pyruvate kinase, and 500 µM GTP. EF-Tu activation reactions were
incubated at 37 ◦C for 30 min and used immediately for mis-aminoacylation. Pre-formed Ser-tRNAAla
was subsequently generated by incubating 10 µM tRNAAla with 950 µM (3H)-Ser, 5 µM activated
EF-Tu, 5 µM E. coli AlaRS C666A, 8 mM ATP, and aminoacylation buffer. Cognate Ala-tRNAAla was
pre-formed in buffering conditions as described above and with 150 µM (14C)-Ala, 200 nM E. coli
AlaRS, and 5 µM tRNAAla. Aminoacylation reactions were incubated for 1 h at 37 ◦C and subsequently
quenched by adding an equal volume of acid phenol chloroform. Following acid phenol chloroform
extraction, aa-tRNAAla was EtOH precipitated, before finally being re-suspended in 100 mM sodium
acetate pH 4.5. To monitor aa-tRNAAla deacylation activity, 150 nM AlaRS variants were incubated
with aminoacylation buffer and pre-formed aa-tRNAAla. Aliquots of the reaction were quenched on 5%
TCA presoaked filter paper at various time points between 0 and 20 min. Quenched reactions were then
washed 3x in 5% TCA, EtOH, dried, and quantified using scintillation counting. Percent deacylation
was determined by the decrease in radiolabeled signal relative to T0.
To monitor ATP consumption, reactions including: 2 µM tRNAAla, 1× aminoacylation buffer,
1 µM AlaRS variants, 0.2 U PPiase, 3 mM (32P – γ) ATP, and either 10 mM alanine or 100 mM serine
were incubated at 37 ◦C. At time points ranging between 3′–30′, aliquots of the reaction mix were
removed and quenched in an equal volume of glacial acetic acid. To monitor the consumption of ATP,
migration of the quenched reactions were monitored by thin-layer chromatography on PEI cellulose
plates. Plates were developed in dipotassium phosphate and imaged using phosphor imaging.
2.10. Pyrophosphate Exchange
Pyrophosphate (PPi) exchange assays were performed at 37 ◦C in HKM buffer (100 mM Na-HEPES,
pH 7.2, 30 mM KCl, 10 mM MgCl2, 2 mM NaF) containing 2 mM ATP, 2 mM (32P) PPi (2–4 cpm/pmol)
and 10 nM of the purified enzyme. The concentrations of the substrates were varied from 0–1 mM for
alanine and 0–50 mM for serine. The reactions were quenched at the selected timepoints by aliquoting
25 µL of the reaction into 970 µL of a charcoal solution (1% charcoal, 5.6% HClO4, and 75 mM PPi).
The quenched solution was then added onto 3 MM Whatman filter discs and vacuum filtered with
three 5 mL washes of water. The discs were then dried and the radioactivity was determined by
liquid scintillation counting. Results were fit to a Michaelis-Menten curve using GraphPad Prism to
determine the steady-state activation kinetics.
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3. Results
3.1. Identification of Suppressor Mutations That Alleviate the AlaRS C666A Growth Defect
It has been previously observed that perturbation of AlaRS proofreading in E. coli leads to
growth defects when compared to wild-type E. coli [13]. To determine if secondary mutations in the
E. coli genome could suppress the growth defects associated with a deficiency in AlaRS proofreading,
suppressor mutants that restore near-normal growth compared to their proofreading-deficient strain
were screened for. Due to the severe growth defects associated with AlaRS-mediated mistranslation,
suppressor mutations were anticipated to act in reducing the mistranslational load on the proteome.
It was speculated that this suppression could possibly occur by increasing the thermodynamic
barrier for EF-Tu discrimination and thus preventing mis-acylated tRNA accumulation into an active
ternary complex [22–24]. Additionally, the E. coli protein ProXP-ST1 was previously shown to have
activity against Ser-tRNAAla in vitro [25]. Therefore it was possible that mutations in the yeaK
gene (gene encoding ProXP-ST1) could increase ProXP-ST1 proofreading activity on mis-serylated
tRNAAla substrates.
Suppressor colonies of the MG1655 AlaRS C666A strain accumulated on LB agar plates without
the need for additional mutagenic manipulation. One initial wild-type-like colony was selected from
the mixed population, colony purified, and genomic DNA (gDNA) was extracted. The isolated gDNA
was further subjected to whole-genome sequencing (WGS) for variant analysis. When compared to
another control sample that was also analyzed by WGS, only one additional mutation was identified in
the suppressor mutant. The identified single nucleotide polymorphism (SNP) was a G1651T mutation
in the alaS gene that when translated, caused a D551Y substitution in AlaRS. Having identified
second-site alaS suppressors, two additional suppressor mutant colonies were isolated from LB agar
plates. Rather than subjecting the two additional mutants to WGS analysis, gDNA was extracted from
these mutants and the DNA was used as the template for PCR to amplify the alaS gene. This alaS
amplicon was used as the template for a Sanger sequencing reaction using a primer with homology
to alaS. Sanger sequencing of the two additional suppressors reported that both of the mutants also
contained secondary mutations in the alaS gene, with both SNPs occurring at nucleotide position
C1681, ultimately resulting in two different substitutions at R561, R561C, and R561S.
While the alaS gene encodes one complete monomeric unit of AlaRS, this gene contains at least
three characterized domains responsible for distinct enzymatic activity including, amino acid activation
and tRNA aminoacylation [26,27], proofreading [9], and a C-terminal C-Ala domain required for
oligomerization that also participates in aminoacylation [28,29]. The three suppressor mutations all
occur in the proofreading domain of AlaRS (Figure 1A). To date, these two amino acid positions have
yet to be characterized or predicted to participate in any proofreading activity. The coordination of the
proofreading domain active site has previously been explored and has indicated that residues involved
in mis-acylated tRNA hydrolysis are evolutionarily conserved (e.g., C666 in E. coli) [30]. To determine if
the two amino acid residues identified in the suppressor screen are also conserved, AlaRS proofreading
domains were aligned across several prokaryotic and eukaryotic model systems. With the exception of
the closely related Salmonella enterica, these amino acid positions do not appear to be evolutionarily
conserved (Figure 1B). Currently, no structural data for the E. coli AlaRS proofreading domain exists.
Using Phyre2 modeling predictions, the position of the suppressor residues were mapped on the AlaRS
structure. Based on these predictions, both residues, D551 and R561 are positioned in potentially
productive regions in the AlaRS proofreading domain for tRNA body interactions, but likely unable to
directly participate in mis-aminoacyl-tRNA hydrolysis (Figure 1C). These preliminary observations
provided the first evidence of second-site AlaRS suppressors that alleviated the growth defect associated
with AlaRS mistranslation in E. coli.
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3.2. Second-Site AlaRS Mutations Alleviate the Slow-Growth AlaRS C666A Phenotype
While the sequencing data indicated second-site mutations in the alaS gene were likely responsible
for the suppression of the AlaRS C666A slow-growth phenotype, it was possible that other mutations
in the suppressor strains may have been missed by our sequencing analysis and the second-site
mutations were a coincidence but not responsible for the suppression. To confirm that the three
identified mutants were acting as the MG1655 AlaRS C666A suppressors, the three mutations were
made in isogenic MG1655 and MG1655 AlaRS C666A strains, creating single and double mutants for
the suppressors. One possibility for these mutants was the potential for the second-site mutants acting
as compensatory mutations for the AlaRS C666A substitution, while single mutants alone may elicit a
separate growth defect.
Upon generation of the six isogenic strains, growth of all of the strains was monitored in LB
liquid media at 37 ◦C. This growth condition has previously been used to highlight the AlaRS C666A
growth defect [13]. Interestingly, all single and double mutant suppressor strains grew as well as
wild-type E. coli (Figure 2A). This observation indicated that suppressor mutations identified from
the various sequencing analyses were acting as suppressors. Furthermore, substitutions at D551 or
R561 alone do not cause any change in growth at 37 ◦C in rich media. As previously eluded to,
perturbation to AlaRS proofreading leads to defects in growth in rich media. It was further shown that
this defect is serine dependent, presumably through elevated levels of Ala to Ser mistranslation [9,13].
To determine if the suppressor mutants also exhibit a serine-dependent growth defect that may have
been masked in rich media, the suppressor mutants were grown in minimal media supplemented
with exogenous serine, and their growth was monitored. Despite the excess non-cognate amino acid
stress, the single and double suppressor mutants were able to grow just as well as wild-type E. coli
(Figure 2B), which may suggest that the level of serine mistranslation was reduced in the presence of
the second-site substitutions.
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Figure 2. Suppressor mutants alleviate AlaRS C666A-associated growth defects. Suppressor mutants
alleviated the AlaRS C666A growth defects in (A) LB (Lysogeny broth) and (B) M9 minimal media
supplemented with non-cognate serine.
3.3. AlaRS C666A Suppressors Do Not Prevent Serine Mistranslation
To directly observe the potential for Ala to Ser mistranslation in the suppressor strains,
a recently described mistranslation reporter [13] was applied to all of the single and double mutants.
The mistranslation reporter utilizes a mutated β-lactamase gene in which an essential serine residue
has been mutated to encode an alanine [31]. Under conditions of high AlaRS fidelity, the mutant
β-lactamase product will be translated and the cells will be unable to grow on β-lactam antibiotics
(e.g., ampicillin). If Ala to Ser mistranslation is occurring, the wildtype β-lactamase protein will be
made and the cells will grow in the presence of the antibiotic. This reporter has recently been used
to show that in the AlaRS C666A variant strain, Ala to Ser mistranslation is occurring in vivo [13].
Upon transformation of the reporter and plating of the suppressor strains, all variants that contained
the C666A allele were able to grow on ampicillin (Figure 3). This observation suggests that the C666A
substitution is sufficient to cause protein mistranslation even in the presence of additional second-site
suppressors. None of the single AlaRS suppressor variants were able to grow in the presence of
antibiotics suggesting that these substitutions alone do not negatively affect the hydrolytic proofreading
activity of these enzymes in vivo. One limitation of this qualitative assay is the inability to discern
quantifiable changes in levels of mistranslated proteins. It is possible that despite the accumulation
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of mistranslated proteins in the second-site suppressors, the levels of mistranslation are still reduced
compared to the single AlaRS C666A variant.
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3.4. Phenotypes Associated with AlaRS-Mediated Proteome Dysregulation Are Alleviated in with the
Second-Site Suppressor Mutations
Previous efforts studying the effect of AlaRS mistranslation in E. coli identified that not only was
protein mistranslation occurring, but the accumulation of mistranslated proteins led to dysregulation
of the E. coli proteome [13]. This observation suggested that regardless of the individual protein that
may contain a misincorporated amino acid, the Ala to Ser substitution itself was not tolerated globally
and caused activation of several stress response cascades that could be reproducibly observed with
population-level analyses. The first indication that protein regulation may be altered in the E. coli AlaRS
strain was the observation that in the absence of AlaRS proofreading, E. coli exhibited an accentuated
slow growth phenotype when grown in rich media at 42 ◦C. The delayed growth response to the heat
stress potentially suggested that these AlaRS proofreading-deficient cells were unable to mount an
adequate response to thermal stress. Total proteome analysis of wild-type and AlaRS C666A strains
further revealed that in the absence of AlaRS proofreading, more than 800 proteins were differentially
enriched or under-represented [13].
Despite the observation that serine mistranslation was still occurring in the suppressor mutants,
it was of interest to determine if the phenotypes associated with the proteome dysregulation in the
AlaRS C666A strain were still present in the suppressor strains. To determine if the suppressor strains
were able to respond to a shift in thermal stress, the suppressor strains were grown in LB media
at 42 ◦C. As had been previously observed [13], the AlaRS C666A strain has an elevated growth
sensitivity at 42 ◦C compared to 37 ◦C (Figures 2A and 4A). However, none of the single or double
suppressor mutants elicited any deviation in growth when compared to wild-type E. coli (Figure 4A).
This observation suggested that the dysregulation associated with the single AlaRS C666A allele was
not present in the suppressor strains.
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Figure 4. Suppressor mutants alleviate AlaRS C666A-associated phenotypes. Second-site suppressors
alleviated the (A) heat stress, (B) swimming, and (C) antibiotic sensitivities previously observed in
the AlaRS C666A mutant. Statistical significance was determined by one-way ANOVA with Tukey
post-hoc comparison (* p < 0.0005).
From the original total proteome analysis, several distinct physiological pathways were identified
to be enriched or under-represented. In addition to many other biological processes, there appeared
to be a defect in motility and membrane integrity that was further assayed for and confirmed using
direct phenotypic analyses [13]. To further support that the global dysregulation was alleviated in
the AlaRS C666A suppressors, all strains were plated on LB agar swimming media, and motility
was monitored. The only strain to exhibit a statistically significant change in motility was the single
AlaRS C666A mutant, as had previously been observed. All of the suppressors were able to swim as
well as wild type (Figure 4B). Perturbations to membrane integrity were monitored by antibiotic disk
diffusion assays. Once again, all suppressor strains were equally sensitive to both ertapenem and
polymixin B as wild-type E. coli, whereas the AlaRS C666A variant was significantly more sensitive to
antibiotic exposure (Figure 4C). The results presented herein highlight that Ala to Ser mistranslation
is not sufficient to cause global proteome dysregulation. Having demonstrated that the second-site
AlaRS suppressors were able to not only alleviate the slow growth defect associated with the AlaRS
C666A variants (Figure 2) but also likely restore the global proteome homeostasis (Figure 4) but still not
prevent Ala to Ser mistranslation (Figure 3), the mechanism for this suppression still remained unclear.
3.5. In Vitro Characterization of the AlaRS C666A Suppressors
Having previously demonstrated that the AlaRS C666A suppressors do not prevent mistranslation
in vivo, biochemical analyses were performed to potentially identify differences in the formation
of the Ser-tRNAAla substrates in vitro. Recombinant AlaRS variants were expressed and purified
from E. coli and in vitro transcribed E. coli tRNAAla was used as a tRNA substrate for all cognate and
non-cognate experimentation. To determine if there were any differences in non-cognate Ser-tRNAAla
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formation, in vitro mis-aminoacylation experiments were performed using all of the AlaRS variants.
The AlaRS C666A editing-defective variant was able to mis-serylate tRNAAla as expected, and all of
the AlaRS suppressor enzymes were also able to mis-aminoacylate tRNAAla (Figure 5A). While the
AlaRS suppressor variants were able to mis-serylate tRNAAla, AlaRS C666A R561C did exhibit a
~50% reduction in Ser-tRNAAla product formation (Figure 5B). Consistent with observations using the
in vivo mistranslation reporter, this in vitro analysis suggests that the AlaRS suppressor variants are
unable to prevent mis-aminoacylation but a substitution of R561C can potentially lead to an overall
decrease in mis-serylated tRNA formation in the cell.
Genes 2020, 11, x FOR PEER REVIEW 11 of 17 
 
5C) while also being unable to form Ser-tRNAAla (Figure 5B). The AlaRS suppressor C666A R561C 
also shows an increased specificity against serine activation as compared to AlaRS C666A (Table 1). 
This increased serine discrimination by the R561C suppressor may explain the ~50% reduction in Ser-
tRNAAla formation (Figure 5B). In contrast, the AlaRS C666A R561S mutant shows similar specificity 
against serine activation as compared to AlaRS C666A (Table 1). This indicates that the R561S 
mutation has no effect on amino activation but instead increases overall proofreading as evidenced 
by the deacylation studies (Figure 5C, D) and ATP futile cycling (Figure 5G, H). Finally, the single 
AlaRS D551Y variant and the suppressor AlaRS C666A D551Y show reduced specificity against 
serine activation as seen in Table 1. However, the AlaRS D551Y variant showed the highest rate of 
deacylation for Ser-tRNAAla (Figure 5E). Thus, the D551Y substitution is likely productive for Ser-
tRNAAla proofreading but not for preventing serine misactivation. 
 
Figure 5. In vitro characterization of AlaRS C666A suppressors. The three identified AlaRS C666A 
suppressors were assayed for (A) mis-serylation activity and results from the (B) AlaRS R561C 
mutants were further analyzed. The proofreading activity of the enzymes were examined over a time 
course for (C) Ser-tRNAAla and (D) Ala-tRNAAla substrates. Furthermore the initial rates of Ser-
Figure 5. In vitro characterization of AlaRS C666A suppressors. The three identified AlaRS C666A
suppressors were assayed for (A) mis-serylation activity and results from the (B) AlaRS R561C
mutants were further analyzed. The proofreading activity of the enzymes were examined over a
time course for (C) Ser-tRNAAla and (D) Ala-tRNAAla substrates. Furthermore the initial rates of
Ser-tRNAAla deacylation were monitored for the (E) single mutants and (F) double mutants. Finally,
ATP consumption was observed for reactions including tRNAAla and (G) serine or (H) alanine.
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In addition to the direct contribution of Ser-tRNAAla product formation, it was possible that
the mechanism for the suppressors could be occurring due to changes in Ser-tRNAAla proofreading.
Pre-formed Ser-tRNAAla was incubated with all of the AlaRS variants and deacylation was monitored
over time. None of the second-site suppressors were able to proofread the mis-serylated tRNA product
similar to wild-type AlaRS levels (Figure 5C). The AlaRS R561S variant enzyme exhibited elevated
levels of cognate Ala-tRNAAla deacylation, with the percent of deacylated substrates reaching ~40%
after 30 min (Figure 5D). Upon further inspection of the initial rates of Ser-tRNAAla deacylation, two of
the single mutant suppressors, AlaRS D551Y and AlaRS R561S appear to be proofreading faster than
the wild-type enzyme (Figure 5E). Furthermore, evaluation of the initial deacylation rates for the
double mutants suggests that AlaRS D551Y C666A and the AlaRS R561S C666A enzymes have slightly
elevated proofreading activities compared to the editing-defective AlaRS C666A enzyme (Figure 5F).
An additional observation made from the in vitro deacylation experiment is that the single AlaRS
R561C variant was unable to deacylate Ser-tRNAAla in trans. As previously described, the AlaRS R561C
variant was unable to form mis-serylated tRNAAla product in vitro, suggesting that an additional
conformational change may have occurred in this enzyme leading to greater fidelity during initial
serine activation that no longer requires proofreading activity in the editing domain. This hypothesis
is further supported by results from the in vivo reporter experiment, which did not reveal Ala to Ser
mistranslation in the MG1655 AlaRS R561C mutant background (Figure 3).
A secondary measure for determining aaRS proofreading activity is through the monitoring
of ATP futile cycling. As has been previously described, the first step in aa-tRNA formation is the
activation of free amino acid with ATP to form an aminoacyl-adenylate. During standard cognate
aa-tRNA reactions, one molecule of ATP is activated per one aa-tRNA formed, ultimately reaching
equilibrium when all tRNA substrates are aminoacylated. Alternatively, when aaRS proofreading
is occurring, the mis-activated substrate will be hydrolyzed and can subsequently be re-activated,
leading to iterative rounds of ATP consumption.
Observations from monitoring ATP cycling suggest that AlaRS R561S was the most
proofreading-proficient AlaRS variant as ATP consumption levels surpassed those of the wild-type
enzyme (Figure 5G). Furthermore, AlaRS R561S displayed increased rates of ATP consumption when
incubated with cognate alanine, consistent with observations that R561S leads to cognate Ala-tRNAAla
deacylation (Figure 5H). While the AlaRS D551Y enzyme displayed the highest rate of Ser-tRNAAla
deacylation in trans, similar levels of ATP consumption were observed when compared to wild-type,
suggesting an imbalance in the rate of deacylation and re-activation. Finally, enzymes containing the
R561C variant had the lowest rate of ATP consumption, which is consistent with deacylation studies
suggesting that these enzymes are unable to proofread Ser-tRNAAla.
To further characterize the AlaRS editing suppressors, amino acid activation was monitored using
a pyrophosphate (PPi) exchange. This assay enables the determination of amino acid activation kinetics
by measuring the accumulation of (32P)-ATP in a reaction containing excess (32P)-PPi. PPi exchange
not only facilitates the determination of aminoacyl-adenylate kinetics, it can also be used to highlight
changes in enzyme specificities for different substrates, such as cognate alanine or non-cognate serine.
Observations from the pyrophosphate exchange assay indicate that the single AlaRS R561C
variant shows increased specificity against serine activation (Table 1). This is consistent with previous
observations where the AlaRS R561C variant was unable to hydrolyze Ser-tRNAAla in trans (Figure 5C)
while also being unable to form Ser-tRNAAla (Figure 5B). The AlaRS suppressor C666A R561C also
shows an increased specificity against serine activation as compared to AlaRS C666A (Table 1).
This increased serine discrimination by the R561C suppressor may explain the ~50% reduction
in Ser-tRNAAla formation (Figure 5B). In contrast, the AlaRS C666A R561S mutant shows similar
specificity against serine activation as compared to AlaRS C666A (Table 1). This indicates that the
R561S mutation has no effect on amino activation but instead increases overall proofreading as
evidenced by the deacylation studies (Figure 5C,D) and ATP futile cycling (Figure 5G,H). Finally,
the single AlaRS D551Y variant and the suppressor AlaRS C666A D551Y show reduced specificity
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against serine activation as seen in Table 1. However, the AlaRS D551Y variant showed the highest
rate of deacylation for Ser-tRNAAla (Figure 5E). Thus, the D551Y substitution is likely productive for
Ser-tRNAAla proofreading but not for preventing serine misactivation.
Table 1. Steady state activation kinetics of AlaRS C666A suppressors. Steady state kinetic parameters
of the AlaRS C666A suppressors for the activation of alanine and serine were determined using
pyrophosphate exchange.
Ala
Ser a (kcat/Km) Specificity b (Ala/Ser)
Km kcat kcat/Km
µM min−1 min−1/µM min−1/µM
E. coli AlaRS 320 ± 150 1246 ± 105 3.91 4.7 × 10−3 ± 1.5 × 10−4 832
AlaRS C666A 263 ± 115 1010 ± 380 3.83 7.3 × 10−3 ± 5 × 10−4 525
AlaRS D551Y 260 ± 76 715 ± 220 2.76 6.9 × 10−3 ± 2.5 × 10−4 400
AlaRS D551Y C666A 217 ± 100 1096 ± 265 5.06 10.4 × 10−3 ± 14 × 10−4 490
AlaRS R561C 203 ± 68 1306 ± 345 6.45 6.7 × 10−3 ± 13 × 10−4 963
AlaRS R561C C666A 190 ± 30 819 ± 88 4.29 5.5 × 10−3 ± 19 × 10−4 780
AlaRS R561S 180 ± 15 1216 ± 125 6.70 8.2 × 10−3 ± 19 × 10−4 817
AlaRS R561S C666A 177 ± 37 791 ± 150 4.46 7.3 × 10−3 ± 5 × 10−4 611
a Kcat /Km was estimated using subsaturating Ser concerntrations from the slope of the equation, V = Kcat[E][S]/Km; b
Measuted in Kcat /Km.
3.6. AlaRS R561C Reduces Ser-tRNAAla Formation
Biochemical characterization of the AlaRS R561C variants suggests this enzyme has an overall
reduction in the potential to form Ser-tRNAAla, as is evident in Figure 5B. This reduced potential to form
Ser-tRNAAla is likely due to an increased specificity against serine during amino acid activation, as seen
in Table 1. Interestingly, the R561C substitution led to a reduction in overall proofreading activity
even with C666 present (Figure 5C). This interpretation is consistent with observations monitoring
ATP consumption (Figure 5G). Taken together, the biochemical analyses suggest that AlaRS R561C is
leading to increased discrimination of serine, independent of AlaRS proofreading. While it is yet to be
explored, the R561C substitution may cause disruption to wild-type AlaRS disulfide bond formation,
leading to changes in enzyme activation and proofreading.
3.7. AlaRS R561S Has Elevated Proofreading Activity
In contrast to observations studying the effect of the AlaRS R561C on aaRS discrimination, the
AlaRS R561S variant appears to be hyper-active in AlaRS proofreading, as indicated by the increased
hydrolytic activity. The AlaRS R561S C666A variant is able to mis-serylate tRNAAla which is consistent
with the observation of Ala to Ser mistranslation in vivo (Figure 3). Furthermore, this enzyme shows
no changes in the discrimination of serine during amino acid activation, as compared to AlaRS C666A
(Table 1). However, the levels of Ser-tRNAAla do appear to be slightly reduced compared to the
AlaRS C666A single mutant (Figure 5A). The elevated proofreading activity is more obvious when
monitoring the deacylation activity directly in editing assays. The R561S variant has elevated rates of
Ser-tRNAAla deacylation compared to wild-type AlaRS (Figure 5E), and the R561S C666A enzyme
has elevated proofreading activity compared to editing-defective AlaRS C666A variant (Figure 5F).
Consistent with these observations is the elevated levels of ATP consumption in enzymes containing
the R561S substitution. The single AlaRS R561S variant had the highest rate of ATP consumption and
the R561S C666A variant had elevated ATP consumption compared to the C666A enzyme (Figure 5G).
Interestingly, the R561S enzyme had elevated levels of deacylation (Figure 5D) and ATP consumption
for cognate Ala-tRNAAla substrates (Figure 5H). This observation provides the first evidence of a
hyper-active proofreading enzyme. Furthermore, the contribution of AlaRS R561S together with the
editing-defective C666A substitution may lead to an overall reduction of Ser-tRNAAla in the cell.
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3.8. AlaRS D551Y Increases Ser-tRNAAla Deacylation in Trans
Compared to observations from the R561 variants, the AlaRS D551Y suppressor is unique in
that the double mutant suppressor enzyme had no change in Ser-tRNAAla formation (Figure 5A).
The mis-serylation experiments including the AlaRS D551Y C666A enzyme were the most variable of
all other enzymes tested. To circumvent this problem, this experimental condition was tested nine total
times compared to the three replicates of the other enzymes. After much consideration, we believe
that this variability is not an artifact of technical error but rather, suggestive of perturbation to the
overall rate of AlaRS activity. Pyrophosphate exchange assays indicate that the AlaRS D551Y C666A
enzyme has the lowest specificity against serine during amino acid activation (Table 1). When studying
proofreading activity directly, AlaRS D551Y had the fastest rate of Ser-tRNAAla deacylation of all
enzymes tested (Figure 5E). Interestingly, the elevated rate of deacylation was not observed when
monitoring the rate of ATP consumption (Figure 5G). Together these results suggest that AlaRS D551Y
is able to efficiently deacylate Ser-tRNAAla in trans. As the D551Y containing-containing enzymes
had reduced specificity against non-cognate serine, this suggests that activation is likely not limited,
but rather likely due to a perturbation during tRNA transfer. While this discrepancy still remains
unclear, the data presented herein do suggest that the AlaRS D551Y substitution likely reduces the
overall Ser-tRNAAla burden caused by the C666A substitution.
4. Discussion
4.1. Fitness Costs Associated with Translational Errors and Disruption of the Aminoacyl-tRNA Pool Are
Amino Acid-Specific
The aforementioned suppressor screen identified an AlaRS allele that leads to increased accuracy
against non-cognate aa-tRNAAla formation. Recombinant AlaRS R561S enzymes displayed elevated
rates of non-cognate Ser-tRNAAla hydrolysis as well as a long-term increase in cognate Ala-tRNAAla
deacylation. This observation provides the first direct evidence of a hyper-accurate AlaRS enzyme,
and to our knowledge, the first experimental validation of an aaRS post-transfer proofreading
domain with increased hydrolytic activity. Interestingly, the single AlaRS R561S mutant displays no
distinguishable phenotypic perturbation compared to wild-type E. coli. This observation suggests
that perturbation to Ala-tRNAAla fidelity may be less tolerated than an overall decrease in tRNAAla
aminoacylation levels.
It has previously been noted that in both bacteria and eukaryotes, perturbation to aaRS fidelity
not only affects rates of protein mistranslation but can also alter intracellular sensing of nutritional
stress and consequently leading to dysregulation of cellular stress [11,12]. AaRSs must maintain
sufficient aa-tRNA levels to keep up with the translational demand for cellular protein synthesis
and also monitor amino acid availability for nutrient sensing. Both of these roles make aaRSs an
important player to maintain and modulate cellular homeostasis. In E. coli the accumulation of
uncharged tRNA will activate the stringent response facilitated by the RelA-dependent accumulation
ppGpp [32,33]. Stringent response activation leads to down-regulation of rRNAs and ribosomal
proteins, ultimately slowing down cellular growth [33,34]. Numerous reports have indicated the
detrimental cost of AlaRS-mediated translational errors, but here we suggest that those errors are more
costly than perturbations to the pool of aa-tRNAAla formation. We have previously suggested that
specific mistranslational errors are more tolerated in the proteome than others [13]. We would now
like to expand on that observation and further suggest that not only are specific mistranslational errors
more or less costly to the proteome, but defects associated with aa-tRNA formation are also amino
acid-dependent as well.
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4.2. Perturbation of AaRS Fidelity Leads to Rapid Acquisition of the AlaRS C666A Variant
One striking observation from this work was the accumulation of AlaRS C666A suppressors
without the necessity for mutagenic manipulation. It has previously been reported that increased levels
of mistranslation, either facilitated by an error-prone aaRS [35] or imbalances in initiator tRNA levels [36]
lead to increased SOS-dependent mutation sampling. This model proposes that increased levels of
mistranslation cause elevated Lon protein levels, ultimately leading to the RecA-dependent degradation
of LexA causing SOS induction. The authors of the aforementioned work first noted decreased antibiotic
sensitivity to the DNA gyrase inhibitor ciprofloxacin during increased protein mistranslation.
Previous work from our group has shown that defects in AlaRS proofreading lead to increased
sensitivity to ciprofloxacin [13]. Similar analysis comparing a proofreading-deficient ThrRS E. coli
strain suggested a slight trend towards improved sensitivity to ciprofloxacin compared to wild type,
although the observed trend was not statistically significant [13]. Together these observations may
suggest that while SOS induction may be occurring in response to increased mistranslation, the cost of
a specific error may affect the potential benefit of this early stress response induction.
Total proteomic analysis of the E. coli AlaRS C666A strain reported a ~1.7× increase in RecA
levels compared to wild type [13]. While predicted correlating trends in both Lon and LexA were
not observed, it is possible that the observed changes in RecA correspond to other observations of
mistranslation causing SOS-dependent mutant sampling. This mechanism may be responsible for the
propensity for the AlaRS C666A suppressor to arise that were identified in this report.
4.3. Secondary AaRS Proofreading Activities Permit Regulation of Translational Quality Control
Half of the aaRSs in E. coli encode for distinct secondary proofreading activities that either
hydrolyze mis-activated aminoacyl-adenylates or mis-aminoacylated tRNAs. Perturbation to these
activities has indicated a wide array of neutral to deleterious outcomes for cells in vivo [10,13,37].
The extensive evolutionary conservation of aaRS proofreading would suggest an important role for
the discriminatory properties of these enzymes that would otherwise not be possible by active site
discrimination alone.
In this work, we have identified an AlaRS variant, AlaRS R561C which sufficiently prevents
serine mistranslation in vivo but is unable to hydrolyze mis-aminoacylated in vitro and elicits no
futile cycling of ATP, consistent with predictions that this enzyme has lost hydrolytic proofreading
activity. This observation raises an interesting idea in that why would AlaRSs maintain an
energetically-unfavorable proofreading activity when an AlaRS variant can exist that is sufficiently
discriminatory and also does not require the consumption of ATP? Of the phenotypes explored in
this report, the E. coli AlaRS R561C variants displayed no differences compared to the wild-type
counterpart E. coli. It is possible that there are other physiologically relevant environments that may
elicit deviations from that trend however, there is another possibility why aaRS proofreading may be
maintained that we would like to propose.
Work from our group and others has continually shown the incredible cost associated with
perturbation to AlaRS proofreading [13,37–39]. However, thinking about aaRSs more globally,
we know that some errors are better tolerated than others [13], and some aaRSs only need proofreading
activity against non-proteinogenic substrates [40,41]. There is a growing body of evidence that aaRS
proofreading activity can also be modulated by environmental changes. Both ThrRS [42] and PheRS [21]
alter proofreading activity upon oxidative stress, both by decreasing and increasing their discriminatory
capacities respectively. Furthermore, ThrRS was recently shown to decrease proofreading activity
upon post-translational acetylation [43]. These observations suggest a potential role for maintaining
secondary proofreading activities as opposed to encoding for ubiquitously sufficient discriminatory
activities in the primary active site. The maintenance of hydrolytic proofreading activities allows
the opportunity to modulate enzyme discrimination during environmental or regulatory changes.
All together suggesting that while it is possible for an aaRS to maintain active site discrimination
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without the necessity for distinct proofreading mechanisms, it abolishes the opportunity for modulation
of proofreading activities and therefore has potentially not been selected for evolutionarily.
5. Conclusions
Aminoacyl-tRNA synthetases are essential enzymes that help maintain the speed and accuracy
of the cellular proteome. It has previously been observed that defects in aaRS fidelity can lead to a
wide array of cellular defects, likely due to the cost of substitution-specific effects on protein dynamics.
Of the aaRSs that have been explored to date, defects in AlaRS proofreading appear to be one of the
most severe, with perturbations to AlaRS fidelity causing global dysregulation of the E. coli proteome.
In this work we used a genetic screen to identify mutations that would suppress the deleterious
AlaRS proofreading-deficient phenotypes observed in E. coli. Through these efforts we identified three
second-site suppressors in the AlaRS proofreading domain that alleviate the growth defects associated
with AlaRS errors, but interestingly do not completely prevent protein mistranslation. Subsequent
biochemical analysis highlighted that all three of the suppressors work through unique mechanisms to
reduce the overall Ser-tRNAAla burden in the cell and these subtle changes are sufficient to restore
proteome regulation in E. coli.
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